Kazia Therapeutics Ltd Sustainability Reports
Kazia Therapeutics Limited is an oncology-focused biotechnology company specializing in the clinical development of innovative pharmaceutical drugs for brain cancer and other solid tumors.
Sector: Professional & technical services
Country: Australia
Exchange: Nasdaq
FIGI: BBG001SCPMJ4
5 reports from 2020 to 2025
